LONDON, May 18 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO) has announced its expansion plans in Asia Pacific.
Chiltern has established two new offices and launched operations in Australia and Singapore – with Singapore acting as the hub for its operations in Southeast Asia. This builds further upon Chiltern's well established operation in India. Chiltern is also in the process of forming a company and establishing operations in China.
Chiltern's Asia Pacific operations will be led by Umakanta Sahoo, Executive Director, Asia Pacific. Commenting on the growth, "Chiltern's expansion will provide a broad platform from which global pharmaceutical and biotech Sponsors can expand their geographic reach with confidence and enhance patient recruitment in the Asia Pacific region," stated Dr. Sahoo.
Dr. Sahoo added, "Chiltern has been serving Asia for 5 years with offices in India and we recently completed centralizing our workforce into a new larger office location in Mumbai. We have built a strong foundation in all areas of clinical development services from which to grow further in the region."
Glenn Kerkhof, Chiltern CEO, stated, "Asia Pacific is one of the foremost emerging markets in our industry. With the current expansion of pharmaceutical R & D needs into the Asia Pacific region, Chiltern is well positioned to meet the needs this growth entails. We are very pleased to provide our clients with access to this market while extending our focus on the delivery of high quality, responsive and better value services to our customers."
Chiltern is currently recruiting experienced clinical staff and plans to grow its workforce in the Asia Pacific region to 70 by the end of 2010, providing full Clinical Development, Biometrics, and Resourcing Solutions services.
To facilitate this growth, we are pleased to announce the appointment of Martin Painter as the Asia Pacific region's Manager of Resourcing Solutions, Chiltern's business unit designed to offer fully integrated solutions to staffing needs. Martin will launch our recruitment and staffing services in the region and joins us from a leading life sciences recruitment company in Singapore.
Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries, has 24 offices within 21 countries, resources in 37 countries and employs nearly 1,400 people globally. Chiltern provides Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions services. Further information: www.chiltern.com.